What is Vertex Pharmaceuticals's change in ar?

Vertex Pharmaceuticals (VRTX) reported change in ar of $86.83M in Q4 2025.

How has Vertex Pharmaceuticals's change in ar changed year-over-year?

Vertex Pharmaceuticals's change in ar increased by 249.7% year-over-year, from $24.83M to $86.83M.

What is the long-term trend for Vertex Pharmaceuticals's change in ar?

Over 2 years (2023 to 2025), Vertex Pharmaceuticals's change in ar has grown at a 103.2% compound annual growth rate (CAGR), from $84.10M to $347.30M.

What does change in ar mean?

The net change in money owed to the company by customers during the period.

Discontinued — last reported Q2 '16

Other

Change in AR

Vertex Pharmaceuticals Change in AR remained flat by 0.0% to $86.83M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 249.7%, from $24.83M to $86.83M. Over 2 years (FY 2023 to FY 2025), Change in AR shows an upward trend with a 103.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement

SectionOther

CategoryLiquidity

SignalLower is better

VolatilityModerate

First reportedQ1 2015

Last reportedQ2 2016

How to read this metric

An increase in receivables relative to revenue may signal slower collections or aggressive revenue recognition, while a decrease suggests improved cash flow efficiency.

Detailed definition

This represents the net change in the balance of amounts owed to the company by customers for goods or services delivere...

Peer comparison

Standard working capital metric; peers in pharmaceuticals monitor this closely to track payer reimbursement cycles.

Metric ID: is_anet_change_in_accounts_receivable

Historical Data

3 years

	FY'23	FY'24	FY'25
Value	$84.10M	$99.30M	$347.30M
YoY Change	—	+18.1%	+249.7%

Range$84.10M – $347.30M

CAGR+103.2%

Avg YoY Growth+133.9%

Median YoY Growth+133.9%

Current Streak2+ years growth

Change in AR at Other Companies

GLW

CorningGLW View metric

Frequently Asked Questions

What is Vertex Pharmaceuticals's change in ar?: Vertex Pharmaceuticals (VRTX) reported change in ar of $86.83M in Q4 2025.
How has Vertex Pharmaceuticals's change in ar changed year-over-year?: Vertex Pharmaceuticals's change in ar increased by 249.7% year-over-year, from $24.83M to $86.83M.
What is the long-term trend for Vertex Pharmaceuticals's change in ar?: Over 2 years (2023 to 2025), Vertex Pharmaceuticals's change in ar has grown at a 103.2% compound annual growth rate (CAGR), from $84.10M to $347.30M.
What does change in ar mean?: The net change in money owed to the company by customers during the period.